Cargando…

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials

Objective: Qili Qiangxin Capsule (QQC), a Chinese patent medicine, is clinically effective in treating dilated cardiomyopathy (DCM). However, the meta-analysis of QCC combined with conventional western medicine (CWM) on DCM remains unexplored. This study aimed to systematically evaluate the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Jingjing, Li, Bin, Wang, Xinlu, Li, Xingyuan, Hu, Yucai, Qiao, Lijie, Zhou, Cheng, Yu, Peng, Sang, Tianqing, Zhu, Mingjun, Wang, Yongxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095857/ https://www.ncbi.nlm.nih.gov/pubmed/35571117 http://dx.doi.org/10.3389/fphar.2022.893602

Ejemplares similares

Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
por: Xiang, Qian, et al.
Publicado: (2022)

Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism
por: Xing, Xiaoxiao, et al.
Publicado: (2023)

Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
por: Yao, Jiafang, et al.
Publicado: (2022)

Retracted: Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
por: Healthcare Engineering, Journal of
Publicado: (2023)

Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure
por: Cui, Xiangning, et al.
Publicado: (2015)

Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat model
por: Han, Xiao, et al.
Publicado: (2022)

Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction
por: XIAO, JUN, et al.
Publicado: (2015)

Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Xu, Xiaoming, et al.
Publicado: (2021)

Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-β1/Smad3 Pathway
por: He, Yaoyao, et al.
Publicado: (2015)

Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms
por: Wang, Tongxing, et al.
Publicado: (2023)

Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis
por: Sun, Jin, et al.
Publicado: (2016)

Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis
por: Zhu, Mingjun, et al.
Publicado: (2022)

Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials
por: Wei, Jingjing, et al.
Publicado: (2022)

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
por: Wei, Jingjing, et al.
Publicado: (2021)

Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial
por: Wang, Yongxia, et al.
Publicado: (2020)

The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy
por: Yue-Chun, Li, et al.
Publicado: (2016)

Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow
por: Guo, Hongxin, et al.
Publicado: (2022)

Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy
por: Huang, Yaomeng, et al.
Publicado: (2023)

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Long-term toxicological studies on the Chinese medicine 2036 Specialty-Qiangxin recipe in rats
por: Zhao, Andong, et al.
Publicado: (2021)

Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients
por: Wang, Yu, et al.
Publicado: (2021)

Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis
por: Zhu, Tingfang, et al.
Publicado: (2022)

Mutations in the Voltage Sensors of Domains I and II of Na(v)1.5 that are Associated with Arrhythmias and Dilated Cardiomyopathy Generate Gating Pore Currents
por: Moreau, Adrien, et al.
Publicado: (2015)

Roles of autophagy-related genes in the therapeutic effects of Xuanfei Pingchuan capsules on chronic obstructive pulmonary disease based on transcriptome sequencing analysis
por: Zhang, Ye, et al.
Publicado: (2023)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Neuroprotective Effects and Mechanisms of Zhenlong Xingnao Capsule in In Vivo and In Vitro Models of Hypoxia
por: Wei, Xia, et al.
Publicado: (2019)

Mixed Hypertrophic and Dilated Phenotype of Cardiomyopathy in a Patient With Homozygous In-Frame Deletion in the MyBPC3 Gene Treated as Myocarditis for a Long Time
por: Blagova, Olga, et al.
Publicado: (2020)

Case Report: Diffuse Large B Cell Lymphoma After Cardiac Transplantation due to Anthracycline-Induced Dilated Cardiomyopathy in Pediatric Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2022)

Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
por: Wang, Lingyan, et al.
Publicado: (2018)

Comparative Pharmacokinetics of Cinobufacini Capsule and Injection by UPLC-MS/MS
por: Li, Ming, et al.
Publicado: (2022)

Emerging roles of microRNAs in septic cardiomyopathy
por: Wu, Mingyan, et al.
Publicado: (2023)

Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT
por: Zhou, Yulu, et al.
Publicado: (2021)

The Pharmacological Mechanism of Guchangzhixie Capsule Against Experimental Colitis
por: Yan, Jing, et al.
Publicado: (2021)

Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology
por: Zhang, Siqin, et al.
Publicado: (2021)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Gene Network Mechanism of Zhilong Huoxue Tongyu Capsule in Treating Cerebral Ischemia–Reperfusion
por: Li, Na, et al.
Publicado: (2022)

Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
por: He, Yumei, et al.
Publicado: (2023)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

Identification of Signature Genes of Dilated Cardiomyopathy Using Integrated Bioinformatics Analysis
por: Wu, Zhimin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m5fk9kdujrc8b81vmi96ssisl6